These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17186591)

  • 21. Calculate the impact of drug benefits when negotiating Medicare risk contracts.
    Capitation Manag Rep; 1997 Apr; 4(4):60-3. PubMed ID: 10175584
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacy utilization and the Medicare Modernization Act.
    Maio V; Pizzi L; Roumm AR; Clarke J; Goldfarb NI; Nash DB; Chess D
    Milbank Q; 2005; 83(1):101-30. PubMed ID: 15787955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic primer on federal fraud and abuse statutes.
    Lynn N
    Benders Health Care Law Mon; 1998 May; ():4-9. PubMed ID: 10181985
    [No Abstract]   [Full Text] [Related]  

  • 24. The new Medicare Advantage a disadvantage for providers?
    O'Hare PK
    Healthc Financ Manage; 2004 Mar; 58(3):36-40. PubMed ID: 15029797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare according to Bush: don't use that "P" word.
    Scott JS
    Healthc Financ Manage; 2003 Mar; 57(3):28-30. PubMed ID: 12747049
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicare and state health care programs: fraud and abuse, civil money penalties and intermediate sanctions for certain violations by health maintenance organizations and competitive medical plans--HHS. Correction to final regulations.
    Fed Regist; 1994 Sep; 59(183):48566-8. PubMed ID: 10137643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Government launches major antifraud initiative.
    Tamborlane TA
    Healthc Financ Manage; 1996 May; 50(5):38-40. PubMed ID: 10157015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stats & facts. Medicare and pharmaceutical coverage.
    Manag Care Interface; 1999 Apr; 12(4):68-9. PubMed ID: 10387395
    [No Abstract]   [Full Text] [Related]  

  • 29. What a Food and Drug lawyer should know about the Medicare Modernization Act.
    Azar AM
    Food Drug Law J; 2004; 59(2):217-22. PubMed ID: 15318393
    [No Abstract]   [Full Text] [Related]  

  • 30. Biased selection and Medicare HMOs: analysis of the 1989-1994 experience.
    Cox DF; Hogan C
    Med Care Res Rev; 1997 Sep; 54(3):259-74; discussion 275-85. PubMed ID: 9437168
    [No Abstract]   [Full Text] [Related]  

  • 31. Medicare and state health care programs: fraud and abuse; safe harbors for protecting health plans--Office of Inspector General, HHS. Final rule.
    Fed Regist; 1996 Jan; 61(17):2122-37. PubMed ID: 10155826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare and Medicaid fraud.
    Stefl ME
    Front Health Serv Manage; 1999; 16(2):1-2. PubMed ID: 10787843
    [No Abstract]   [Full Text] [Related]  

  • 33. The Extrapolation Conundrum: Finding a Unified Theory for the Use of Statistical Sampling in Medicare Fraud Cases Brought Under the False Claims Act.
    Reilly T
    Seton Hall Law Rev; 2017; 47(4):1103-26. PubMed ID: 28820563
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicare and state health care programs: fraud and abuse, civil money penalties and intermediate sanctions for certain violations by health maintenance organizations and competitive medical plans--HHS. Final rule.
    Fed Regist; 1994 Jul; 59(135):36072-87. PubMed ID: 10136015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The continuing cost of privatization: extra payments to Medicare Advantage plans in 2008.
    Biles B; Adrion E; Guterman S
    Issue Brief (Commonw Fund); 2008 Sep; 43():1-15. PubMed ID: 18807648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HCFA: PROs should probe billing fraud.
    Gardner J
    Mod Healthc; 1998 Nov; 28(45):2-3. PubMed ID: 10187309
    [No Abstract]   [Full Text] [Related]  

  • 37. Protecting the Medicare trust fund.
    Optometry; 2011 Apr; 82(4):256-8. PubMed ID: 21563352
    [No Abstract]   [Full Text] [Related]  

  • 38. New scrutiny on improper payments. Federal government heightens focus on estimating error.
    Bowman S
    J AHIMA; 2004; 75(10):18-9. PubMed ID: 15559834
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.
    Maclure M
    Milbank Q; 2005; 83(1):131-47. PubMed ID: 15787956
    [No Abstract]   [Full Text] [Related]  

  • 40. 2003 Red Book reveals cost-saving recommendations.
    Prophet-Bowman S
    J AHIMA; 2003 Sep; 74(8):71-3. PubMed ID: 14515526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.